SCHEMBL9059622

SCHEMBL9059622

COc1ccc(NC(=N)N(C)C)c(-c2ccccc2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
LMNA P02545 2/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
KDM4E B2RXH2 3/20 0.45
KMT2A Q03164 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HDAC8 Q9BY41 2/20 0.42
BACE1 P56817 2/20 0.42
GAA P10253 5/20 0.41
HDAC3 O15379 1/20 0.41
HDAC1 Q13547 1/20 0.41
NCOR2 Q9Y618 1/20 0.41
MAPT P10636 1/20 0.41
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 1/20 0.40
PIN1 Q13526 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9311505 0.99 ALDH1A1 (0.44) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
SCHEMBL9310567 0.89 CHRM3 (0.47) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
SCHEMBL9059661 0.83 ALDH1A1 (0.49) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
Fumaric Acid SCHEMBL9311538 0.81 CHRM3 (0.46) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
SCHEMBL16438566 0.80 ALDH1A1 (0.53) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
SCHEMBL18415466 0.80 ALDH1A1 (0.53) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
SCHEMBL9311252 0.79 FABP4 (0.49) ALDH1A1HTTSMN1; SMN2KDM4EKMT2A
SCHEMBL17206120 0.78 HSD17B1 (0.55) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
SCHEMBL9060350 0.78 CHRM1 (0.36) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2
SCHEMBL9310798 0.76 NPC1 (0.44) ALDH1A1L3MBTL1LMNAHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996017612-A1 USE OF SUBSTITUTED PHENYLAMIDINE AND PHENYLGUANIDINE COMPOUNDS FOR THE TREATMENT OF CEREBRAL AND CARDIAC ISCHAEMIA, CONVULSION AND SICKLE CELL ANAEMIA KNOLL AKTIENGESELLSCHAFT (DE) 1996-06-13 WO disclosed
EP-0536151-B1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM BOOTS CO PLC (GB) 1994-09-14 EP disclosed
US-5302720-A Biphenyl-substituted guanidine derivatives useful as hypoglycaemic agents THE BOOTS COMPANY (GB) 1994-04-12 US disclosed
EP-0536151-A1 ORTHOSUBSTITUTED BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM. BOOTS CO PLC (GB) 1993-04-14 EP disclosed
WO-1992000273-A1 ORTHOSUBSTITUTED BIPHENYL AMIDINE AND BIPHENYL GUANIDINE DERIVATIVES AND ANTIDIABETIC OR HYPOGLYCAEMIC AGENTS CONTAINING THEM THE BOOTS COMPANY PLC (GB) 1992-01-09 WO disclosed